Skip to main content
SpringerLink
Log in

Atazanavir: profile report

  • Drugs and Profile Reports
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table

Notes

  1. The use of tradenames is for product identification purposes only and does not imply endorsement.

References

  1. Goldsmith DR, Perry CM. Atazanavir. Drugs 2003; 20 (6): 1679–93.

    Article  Google Scholar 

  2. Piliero PJ. Atazanavir: a viewpoint. Drugs 2003; 20 (6): 1694–5.

    Article  Google Scholar 

  3. Murphy RL. Atazanavir: a viewpoint. Drugs 2003; 20 (6): 1694–5.

    Article  Google Scholar 

  4. Sanne I, Piliero P, Squires K, et al. Results of a phase 2 clinical trial at 48 weeks (AI424–007): a dose-ranging, safety, and efficacy comparative trial of atazanavir at three doses in combination with didanosine and stavudine in antiretroviral-naive subjects. J Acquir Immune Defic Syndr 2003 Jan 1; 32 (1): 18–29.

    Article  PubMed  CAS  Google Scholar 

  5. Piliero PJ. Atazanavir: a novel HIV-1 protease inhibitor. Expert Opin Investig Drugs 2002 Sep; 11 (9): 1295–301.

    Article  PubMed  CAS  Google Scholar 

  6. Robinson BS, Riccardi KA, Gong Y, et al. BMS-232632, a highly potent human immunodeficiency virus protease inhibitor that can be used in combination with other available antiretroviral agents. Antimicrob Agents Chemother 2000 Aug; 44 (8): 2093–9.

    Article  PubMed  CAS  Google Scholar 

  7. Colonno R, Rose R, Cianci C, et al. Emergence of atazanavir resistance and maintenance of susceptibility to other PIs is associated with an I50L substitution in HIV protease [abstract no. 597 plus poster]. 10th Conference on Retroviruses and Opportunistic Infections; 2003 Feb 10–14; Boston

  8. Squires KE, Thiry A, Giordano M, et al. Atazanavir (ATV) qd vs efavirenz (EFV) qd with fixed-dose zidovudine (ZDV) and lamivudine (3TC) bid: comparison of antiviral efficacy and safety: 48-week results from BMS AI424–034 phase III pivotal study [poster]. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy; 2002 Sep 27–30; San Diego

  9. Haas DW, Zala C, Schrader S, et al. Therapy with atazanavir plus saquinavir in patients failing highly active antiretroviral therapy: a randomized comparative pilot trial. AIDS 2003 Jun 17; 17 (9): 1339–49.

    Article  PubMed  CAS  Google Scholar 

  10. Murphy R, Pokrovskiy V, Rozenbaum W, et al. Long-term efficacy and safety of atazanavir with stavudine and lamivudine in patients previously treated with nelfinavir or ATV: 108-week results of BMS Study 008/044 [abstract no. 555 plus poster]. 10th Conference on Retroviruses and Opportunistic Infections; 2003 Feb 10–14; Boston

  11. Bristol-Myers Squibb Company. BMS-232632: Atazanavir Briefing Document May-2003 [online]. Available from URL: http://www.fda.gov/ohrms/dockets/ac/03/briefing/3950B1_01_BristolMyersSquibb-Atazanavir.pdf [Accessed 2003 May 15]

  12. Riddler S, Smit E, Cole S, et al. Impact of HIV infection and HAART on serum lipids in men. JAMA 2003 Jun 11; 289 (22): 2978–82.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Research Initiative, Albany Medical College, Albany, New York, USA

    Peter J. Piliero

  2. Northwestern University, Chicago, Illinois, USA

    Robert L. Murphy

Authors
  1. Peter J. Piliero
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert L. Murphy
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Piliero, P.J., Murphy, R.L. Atazanavir: profile report. Drugs Ther. Perspect 19, 5–7 (2003). https://doi.org/10.2165/00042310-200319120-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200319120-00002

Keywords

Search

Navigation